Table 4. Performance of AutoPrognosis in the diabetic patient subgroup.

Model	AUC-ROC (No diabetes)	AUC-ROC (Diabetes)
Framingham score	0.724 ± 0.004	0.578 ± 0.018
AutoPrognosis	0.774 ± 0.005	0.713 ± 0.010

Performance of AutoPrognosis and the Framingham score validated separately on a testing cohort of diabetic patients (1,790 participants), and a testing cohort of non-diabetic patients (40,570 participants) via 10-fold cross-validation. AutoPrognosis was trained using the entire training cohort that combines both diabetic and non-diabetic individuals (381,244 participants).